Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-07-25

FDA Approved: CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% — Original Application (TruPharma LLC)

View source ↗

Summary

FDA approved TruPharma LLC's clotrimazole topical solution 1% as an original application (ANDA) for treatment of common cutaneous fungal infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Clotrimazole topical solution 1% (USP) (clotrimazole topical solution USP 1%)

Snippet

ORIG AP for CLOTRIMAZOLE TOPICAL SOLUTION USP, 1% (CLOTRIMAZOLE TOPICAL SOLUTION USP, 1%)